Alphatec (ATEC) vs Integra LifeSciences (IART)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Integra LifeSciences (IART) has outperformed Alphatec (ATEC) over the past year, gaining 10.0% versus a loss of 67.1%. Over five years, ATEC leads with a -36.8% price change compared with -79.6% for IART. Integra LifeSciences is the larger company by market cap ($1.03 billion vs $1.02 billion), about 1.0 times the size, while Alphatec is growing revenue faster (+25.0% vs +1.5%).
On valuation, Integra LifeSciences trades at a lower forward P/E (5.6x vs 12.0x for Alphatec). Alphatec converts more of its revenue into profit, with a net margin of -18.8% versus -31.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATEC | IART |
|---|---|---|
| Share price | $6.68 | $13.25 |
| Market cap | $1.02B | $1.03B |
| 1-day change | -3.19% | -2.21% |
| YTD return | -68.25% | +6.68% |
| 1-year return | -67.11% | +10.05% |
| 5-year return | -36.80% | -79.57% |
| P/E ratio (TTM) | — | 77.94 |
| Forward P/E | 11.97 | 5.59 |
| EPS (TTM) | $-0.57 | $0.17 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $764.15M | $1.64B |
| Revenue growth (YoY) | +24.95% | +1.53% |
| Net income (latest FY) | $-143.36M | $-516.47M |
| Gross margin | 69.60% | 50.86% |
| Operating margin | -10.75% | -30.17% |
| Net margin | -18.76% | -31.58% |
| 52-week high | $23.29 | $20.49 |
| 52-week low | $6.63 | $8.70 |
| Distance from 52-week high | -71.32% | -35.33% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +93.56% | +18.26% |
| Average volume | 3.38M | 1.05M |
| Shares outstanding | 153.33M | 77.80M |
| Employees | 913 | 4,427 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IART has outperformed ATEC by 77.2 percentage points over the past year.
- Alphatec is more profitable, keeping -18.8 cents of every revenue dollar as net income versus -31.6 cents for Integra LifeSciences.
- Alphatec grew revenue faster in its latest fiscal year (+24.95% vs +1.53%).
About Alphatec
ATEC stock →Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts.
Health Care · Medical/Dental Instruments · 913 employees
About Integra LifeSciences
IART stock →Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments.
Health Care · Medical/Dental Instruments · 4,427 employees
ATEC vs IART FAQ
Which is bigger, Alphatec or Integra LifeSciences?
Integra LifeSciences (IART) is larger, with a market capitalization of $1.03B compared with $1.02B for Alphatec (ATEC).
Which stock has performed better over the past year, ATEC or IART?
IART returned +10.05% over the past 12 months, compared with -67.11% for ATEC (price return, excluding dividends). Past performance does not predict future results.
Are Alphatec and Integra LifeSciences in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.